Pneumocystis pneumonia in children

Vasilios Pyrgos1, Shmuel Shoham, Emmanuel Roilides

  • 1Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA. walsht@mail.nih.gov

Insights

Pneumocystis pneumonia (PCP) is a serious infection in immunocompromised children, often affecting those with T-lymphocyte deficiencies. Early diagnosis and appropriate treatment are crucial for managing this life-threatening condition.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Critical Care Medicine

Background:

  • Pneumocystis pneumonia (PCP) poses a significant threat to immunocompromised children.
  • Risk factors include lymphoid malignancies, HIV, corticosteroid use, transplantation, and primary immunodeficiencies.
  • T-lymphocyte quantitative and qualitative defects are central to susceptibility.

Purpose of the Study:

  • To review the diagnosis, treatment, and prophylaxis of Pneumocystis pneumonia in pediatric patients.
  • To highlight the importance of understanding PCP pathogenesis for future therapeutic advancements.

Main Methods:

  • Diagnosis relies on direct examination or PCR of respiratory secretions.
  • Treatment typically involves trimethoprim-sulphamethoxazole.
  • Alternative therapies include pentamidine, atovaquone, and specific antibiotic combinations.

Main Results:

  • PCP is a life-threatening opportunistic infection in vulnerable pediatric populations.
  • Effective diagnostic tools and multiple therapeutic options are available.
  • Prophylaxis can mitigate, but not entirely prevent, PCP incidence.

Conclusions:

  • Prompt diagnosis and treatment are essential for improving outcomes in pediatric PCP.
  • Further research into PCP pathogenesis is vital for developing novel interventions.
  • Comprehensive management strategies are necessary for high-risk immunocompromised children.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...